drug · small molecule
IkT-001
Phase 3updated 3mo agoby $IKT Inhibikase Therapeutics, Inc.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying IkT-001
- phase3Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- phase3An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- phase1A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg
- phase2A Phase 2 Study of IkT-001Pro in Pulmonary Arterial Hypertension (PAH)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 33m ago
Found something off?
comments(0)
5-min edit window · permanent after that